SMS PHARMACEUTICALS
Back to Balance Sheet
|
SMS PHARMACEUTICALS Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹11 Cr | ₹5.67 Cr | ₹2.75 Cr | ₹8.12 Cr | ₹7.01 Cr |
What is the latest Contingent Liabilities ratio of SMS PHARMACEUTICALS ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹11 Cr |
| Mar2024 | ₹5.67 Cr |
| Mar2023 | ₹2.75 Cr |
| Mar2022 | ₹8.12 Cr |
| Mar2021 | ₹7.01 Cr |
How is Contingent Liabilities of SMS PHARMACEUTICALS Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹11 Cr | 94.02 | |
| Mar2024 | ₹5.67 Cr | 105.88 | |
| Mar2023 | ₹2.75 Cr | -66.09 | |
| Mar2022 | ₹8.12 Cr | 15.77 | |
| Mar2021 | ₹7.01 Cr | - | |
Compare Contingent Liabilities of peers of SMS PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SMS PHARMACEUTICALS | ₹3,180.6 Cr | 1.1% | 9.7% | 39% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹415,073.0 Cr | -0% | -3.2% | -5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹172,248.0 Cr | 4% | 5.2% | 11.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹134,121.0 Cr | 2.4% | 4.5% | 18.3% | Stock Analytics | |
| CIPLA | ₹118,423.0 Cr | -3.5% | -1.5% | -2.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,462.0 Cr | -3.2% | -3.3% | -10.6% | Stock Analytics | |
SMS PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SMS PHARMACEUTICALS | 1.1% |
9.7% |
39% |
| SENSEX | -2.6% |
-1.3% |
7.2% |
You may also like the below Video Courses